Literature DB >> 7870047

Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site.

K A Wafford1, M Kathoria, C J Bain, G Marshall, B Le Bourdellès, J A Kemp, P J Whiting.   

Abstract

The mammalian N-methyl-D-aspartate (NMDA) receptor complex is though to consist of an NR1 subunit in combination with one or more of the four NR2 subunits (A, B, C, and D). When corresponding cDNAs are expressed in Xenopus oocytes, ion channels with the characteristic profile of NMDA receptors are formed. The receptor is unique in requiring two coagonists, glutamate and glycine, for activation of the channel. We have used site-directed mutagenesis to study amino acids in the human NR1 subunit that contribute to the glycine binding site of the NMDA receptor without affecting the agonist site for glutamate. Mutations to D481 and K483 produced receptors with up to 160-fold lower affinities for glycine, as well as other agonists and partial agonists, without affecting maximum current size or the degree of agonist efficacy. The D481A mutation also led to 40-50-fold lower affinities for two structurally diverse glycine site antagonists. From these data we propose that the carboxyl group of this aspartate interacts with the amino moiety of glycine and the equivalent group contained in other agonists and antagonists.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7870047

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  28 in total

Review 1.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 2.  Ionotropic and metabotropic glutamate receptor structure and pharmacology.

Authors:  James N C Kew; John A Kemp
Journal:  Psychopharmacology (Berl)       Date:  2005-02-25       Impact factor: 4.530

3.  Alternative RNA splicing of the NMDA receptor NR1 mRNA in the neurons of the teleost electrosensory system.

Authors:  D Bottai; L Maler; R J Dunn
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

4.  Identification of amino acid residues of the NR2A subunit that control glutamate potency in recombinant NR1/NR2A NMDA receptors.

Authors:  L C Anson; P E Chen; D J Wyllie; D Colquhoun; R Schoepfer
Journal:  J Neurosci       Date:  1998-01-15       Impact factor: 6.167

5.  Allosteric modulation of [3H]-CGP39653 binding through the glycine site of the NMDA receptor: further studies in rat and human brain.

Authors:  M Mugnaini; P Meoni; B Bunnemann; M Corsi; N G Bowery
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

6.  Characterization of a soluble ligand binding domain of the NMDA receptor regulatory subunit NR3A.

Authors:  Yongneng Yao; Mark L Mayer
Journal:  J Neurosci       Date:  2006-04-26       Impact factor: 6.167

7.  Expression and characterization of a glycine-binding fragment of the N-methyl-D-aspartate receptor subunit NR1.

Authors:  J Miyazaki; S Nakanishi; H Jingami
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

8.  Novel alternative splicing predicts a truncated isoform of the NMDA receptor subunit 1 (NR1) in embryonic rat brain.

Authors:  J M Campusano; M E Andrés; K Magendzo; J Abarca; L Tapia-Arancibia; G Bustos
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

9.  AMPA receptors and bacterial periplasmic amino acid-binding proteins share the ionic mechanism of ligand recognition.

Authors:  M Lampinen; O Pentikäinen; M S Johnson; K Keinänen
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

10.  Three pairs of cysteine residues mediate both redox and zn2+ modulation of the nmda receptor.

Authors:  Y Choi; H V Chen; S A Lipton
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.